Regional Variations in the Management of Primary Hyperparathyroidism in Sweden: Population-based Case-control Study

Overview

Journal BJS Open

Publisher Oxford University Press

Specialty General Surgery

Date 2024 Feb 7

PMID 38323883

Authors

David Thorsteinsson

Fredrik Granath

Robert Branstrom

Anna Koman

Jan Zedenius

Inga-Lena Nilsson

Affiliations

Soon will be listed here.

Abstract

Background: Substantial disparities in the utilization of parathyroidectomy for primary hyperparathyroidism have been reported. This study aimed to analyse regional variations in parathyroidectomy incidence with respect to the patient's disease burden and socioeconomic status.

Methods: A population-based case-control study included all patients with primary hyperparathyroidism who underwent parathyroidectomy in Sweden between 2008 and 2017 and 10 matched controls. Data on demographic and socioeconomic variables, co-morbidities and drug prescriptions were collected from relevant national registers. Conditional logistic regression was used to analyse predictors of parathyroidectomy.

Results: A total of 8626 patients with primary hyperparathyroidism (77% women) underwent parathyroidectomy during the study interval. The annual incidence of parathyroidectomy was 9.0 per 100 000 persons. The annual age-adjusted regional incidences of parathyroidectomy varied between 3.3 and 16.9 operations per 100 000 inhabitants. Except for a small underrepresentation of patients with lower education, no effect of socioeconomic variables was observed. Compared with matched controls, the parathyroidectomy group had increased odds ratios of having developed classical symptoms of primary hyperparathyroidism and being prescribed medication against cardiovascular disorders and psychiatric illness at the time of parathyroidectomy. Increased risks of kidney stones and osteoporosis were observed 5 years before parathyroidectomy. Patients with primary hyperparathyroidism selected for parathyroidectomy from regions with a low incidence of operations had a higher prevalence of kidney stones, osteoporosis and hypertension, as well as larger adenomas and higher calcium levels at the time of parathyroidectomy compared with patients in high-incidence regions.

Conclusion: The considerable variation in parathyroidectomy seems more likely associated with different clinical thresholds for detection of primary hyperparathyroidism and referral to surgery than socioeconomic disparities.

References

Yu N, Donnan P, Murphy M, Leese G . Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UK. Clin Endocrinol (Oxf). 2009; 71(4):485-93. DOI: 10.1111/j.1365-2265.2008.03520.x. View

Wilhelm S, Wang T, Ruan D, Lee J, Asa S, Duh Q . The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surg. 2016; 151(10):959-968. DOI: 10.1001/jamasurg.2016.2310. View

Bollerslev J, Rejnmark L, Zahn A, Heck A, Appelman-Dijkstra N, Cardoso L . European Expert Consensus on Practical Management of Specific Aspects of Parathyroid Disorders in Adults and in Pregnancy: Recommendations of the ESE Educational Program of Parathyroid Disorders. Eur J Endocrinol. 2021; 186(2):R33-R63. PMC: 8789028. DOI: 10.1530/EJE-21-1044. View

Wu B, Haigh P, Hwang R, Ituarte P, Liu I, Hahn T . Underutilization of parathyroidectomy in elderly patients with primary hyperparathyroidism. J Clin Endocrinol Metab. 2010; 95(9):4324-30. PMC: 2936062. DOI: 10.1210/jc.2009-2819. View

Weber T, Dotzenrath C, Dralle H, Niederle B, Riss P, Holzer K . Management of primary and renal hyperparathyroidism: guidelines from the German Association of Endocrine Surgeons (CAEK). Langenbecks Arch Surg. 2021; 406(3):571-585. DOI: 10.1007/s00423-021-02173-1. View

Clerici T, Warschkow R, Triponez F, Brandle M . National survey on the management of primary hyperparathyroidism by Swiss endocrinologists. Langenbecks Arch Surg. 2007; 392(5):611-5. DOI: 10.1007/s00423-007-0154-9. View

Koman A, Pernow Y, Branstrom R, Nilsson I, Granath F . Neuropsychiatric Comorbidity in Primary Hyperparathyroidism Before and After Parathyroidectomy: A Population Study. World J Surg. 2022; 46(6):1420-1430. PMC: 9054898. DOI: 10.1007/s00268-022-06485-1. View

Ganesan C, Weia B, Thomas I, Song S, Velaer K, Seib C . Analysis of Primary Hyperparathyroidism Screening Among US Veterans With Kidney Stones. JAMA Surg. 2020; 155(9):861-868. PMC: 7391180. DOI: 10.1001/jamasurg.2020.2423. View

Alobuia W, Meng T, Cisco R, Lin D, Suh I, Kurella Tamura M . Racial disparities in the utilization of parathyroidectomy among patients with primary hyperparathyroidism: Evidence from a nationwide analysis of Medicare claims. Surgery. 2021; 171(1):8-16. PMC: 8688157. DOI: 10.1016/j.surg.2021.05.037. View

10.

Palmer M, Jakobsson S, Akerstrom G, Ljunghall S . Prevalence of hypercalcaemia in a health survey: a 14-year follow-up study of serum calcium values. Eur J Clin Invest. 1988; 18(1):39-46. DOI: 10.1111/j.1365-2362.1988.tb01163.x. View

11.

Pretorius M, Lundstam K, Heck A, Fagerland M, Godang K, Mollerup C . Mortality and Morbidity in Mild Primary Hyperparathyroidism: Results From a 10-Year Prospective Randomized Controlled Trial of Parathyroidectomy Versus Observation. Ann Intern Med. 2022; 175(6):812-819. DOI: 10.7326/M21-4416. View

12.

Pappachan J, Lahart I, Viswanath A, Borumandi F, Sodi R, Metzendorf M . Parathyroidectomy for adults with primary hyperparathyroidism. Cochrane Database Syst Rev. 2023; 3:CD013035. PMC: 9995748. DOI: 10.1002/14651858.CD013035.pub2. View

13.

Enell J, Bayadsi H, Lundgren E, Hennings J . Primary Hyperparathyroidism is Underdiagnosed and Suboptimally Treated in the Clinical Setting. World J Surg. 2018; 42(9):2825-2834. PMC: 6097779. DOI: 10.1007/s00268-018-4574-1. View

14.

Ludvigsson J, Andersson E, Ekbom A, Feychting M, Kim J, Reuterwall C . External review and validation of the Swedish national inpatient register. BMC Public Health. 2011; 11:450. PMC: 3142234. DOI: 10.1186/1471-2458-11-450. View

15.

Wettermark B, Hammar N, Fored C, MichaelFored C, Leimanis A, Olausson P . The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2006; 16(7):726-35. DOI: 10.1002/pds.1294. View

16.

Lundstam K, Pretorius M, Bollerslev J, Godang K, Fagerland M, Mollerup C . Positive Effect of Parathyroidectomy Compared to Observation on BMD in a Randomized Controlled Trial of Mild Primary Hyperparathyroidism. J Bone Miner Res. 2023; 38(3):372-380. DOI: 10.1002/jbmr.4763. View

17.

Axelsson K, Wallander M, Johansson H, Harvey N, Vandenput L, McCloskey E . Analysis of Comorbidities, Clinical Outcomes, and Parathyroidectomy in Adults With Primary Hyperparathyroidism. JAMA Netw Open. 2022; 5(6):e2215396. PMC: 9166253. DOI: 10.1001/jamanetworkopen.2022.15396. View

18.

Bilezikian J, Silverberg S, Bandeira F, Cetani F, Chandran M, Cusano N . Management of Primary Hyperparathyroidism. J Bone Miner Res. 2022; 37(11):2391-2403. DOI: 10.1002/jbmr.4682. View

19.

Johansson N, Jakobsson N, Svensson M . Regional variation in health care utilization in Sweden - the importance of demand-side factors. BMC Health Serv Res. 2018; 18(1):403. PMC: 5987462. DOI: 10.1186/s12913-018-3210-y. View

20.

Christensson T, Hellstrom K, WENGLE B, ALVERYD A, Wikland B . Prevalence of hypercalcaemia in a health screening in Stockholm. Acta Med Scand. 1976; 200(1-2):131-137. DOI: 10.1111/j.0954-6820.1976.tb08208.x. View